Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Authors :: Ramaekers, BLT
Riemsma, R
Tomini, F
Deshpande, S
Duffy, S
Armstrong, N
Severens, Hans
Kleijnen, J
Joore, M
Ramaekers, BLT
Riemsma, R
Tomini, F
Deshpande, S
Duffy, S
Armstrong, N
Severens, Hans
Kleijnen, J
Joore, M
Source :: Ramaekers , BLT , Riemsma , R , Tomini , F , Deshpande , S , Duffy , S , Armstrong , N , Severens , H , Kleijnen , J & Joore , M 2016 , ' Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal ' , Pharmacoeconomics (Print) , pp. 1-12 .
Publication Year :: 2016

Database :: OAIster
Journal :: Ramaekers , BLT , Riemsma , R , Tomini , F , Deshpande , S , Duffy , S , Armstrong , N , Severens , H , Kleijnen , J & Joore , M 2016 , ' Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal ' , Pharmacoeconomics (Print) , pp. 1-12 .
Notes :: application/pdf, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1313620735
Document Type :: Electronic Resource

Tools